OSSTEC Company Market Research Report

Company Overview

• Name: OSSTEC Ltd

• Mission: OSSTEC strives to empower people to be the best they can be by developing leading technology to improve patient outcomes post knee replacement. Their mission blends engineering and healthcare to advance orthopaedics for a healthier, active future.

• Founded: 2021

• Founder: Dr. Maxwell Munford

• Key People:

• Dr. Maxwell Munford - CEO

• Prof. Jonathan Jeffers - CTO

• Mr. Alex Liddle - CCO

• Dominique Kleyn - Chair

• Arron Hughes - Principal Engineer

• Dr. Jennifer Stoddart - Engineering Lead

• Frederik Masure - Engineering Lead

• Hana Fox - Engineering Lead

• Jess Allen - Quality & Regulatory Lead

• Colin Dudrey-Harvey - Test Engineer

• Dr. Ruben Doyle - Advisor

• Dr. Shaaz Ghouse - Advisor

• Headquarters: Imperial College London, Exhibition Road, London, SW7 2AZ, UK

• Number of Employees: 8 people

• Revenue: No information available

• Known For: OSSTEC is known for its innovative knee implants that incorporate lattice technology closely matching native bone properties for optimized implant fixation and durable bone structure.

Products

Knee Implants

• Description: OSSTEC offers additive manufactured bone healing platform technology applied in partial knee implants.

• Key Features:

• Stiffness Matched to Bone: The implants mimic the porous trabecular structure of bone, allowing natural load transfer and reducing stress shielding.

• Cementless Fixation: Provides long-term biologic fixation without the need for bone cement.

• Additive Manufacturing: Allows for design freedom and reduces waste and production costs.

• Bone Maintenance: Encourages healthier bone growth and increased patient satisfaction.

Recent Developments

• Investment and Funding:

• Closed £1.2 million funding round in 2023.

• A subsequent £2 million investment round was closed in early 2024.

• Product Launches:

• Unveiled their first product globally in 2023.

• Exhibited at international forums such as ISTA (New York), AAHKS (Dallas), and AAOS (Las Vegas).

• Partnerships and Recognitions:

• Collaborating with leading medical institutions and organizations in the UK.

• Recognized for excellence in technological innovation, receiving nominations from UK Business Angels Association and EISA.

• Participation in the Shott ScaleUp Accelerator program.

• Awards and Nominations:

• Finalist for Healthtech Business of the Year at the Go:Tech Awards.

• Nominated for Best SEIS Investee Company 2023.

• CEO Maxwell Munford was nominated for Entrepreneur of the Year.

• Research and Publications:

• Conducted extensive research presented in multiple publications such as "Extensive characterisation of 3D printed biomimetic porous structures for orthopaedic applications."

• Research demonstrated that stiffness-matched implants enable more natural load transfer and bone growth.

Additional Notes:
OSSTEC continues to make strides in the orthopaedics industry, promising technological advancements through its pioneering lattice technology and its commitment to transforming knee replacement implants. Their dedication to R&D and strategic partnerships sets the stage for future innovation and market expansion.